2001
DOI: 10.1016/s0006-8993(01)02464-7
|View full text |Cite
|
Sign up to set email alerts
|

Degradation of c-Fos protein expressed by N-methyl-d-aspartic acid in nuclear fractions of murine hippocampus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2002
2002
2006
2006

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 29 publications
0
7
0
Order By: Relevance
“…Transcription factors whose functional activity is regulated at the level of their degradation include NFB (Desterro et al, 2000), c-Myc (Sears et al, 1999), and c-Fos (Ferrara et al, 2003), among others. In many instances, phosphorylation is a key regulator of the stability of a transcription factor, as has been shown for c-Fos Tsurumi et al, 1995), Fos-related antigen-1 (Fra-1) (Vial and Marshall, 2003), Fra-2 (Manabe et al, 2001), c-Jun (Fuchs et al, 1996), JunB (Fuchs et al, 1997), ATF2 (Fuchs et al, 2000), and p53 (Buschmann et al, 2001). Our studies thus add ⌬FosB to this list of transcription factors whose functional activity is regulated through its phosphorylated-dependent stability.…”
Section: Discussionmentioning
confidence: 96%
“…Transcription factors whose functional activity is regulated at the level of their degradation include NFB (Desterro et al, 2000), c-Myc (Sears et al, 1999), and c-Fos (Ferrara et al, 2003), among others. In many instances, phosphorylation is a key regulator of the stability of a transcription factor, as has been shown for c-Fos Tsurumi et al, 1995), Fos-related antigen-1 (Fra-1) (Vial and Marshall, 2003), Fra-2 (Manabe et al, 2001), c-Jun (Fuchs et al, 1996), JunB (Fuchs et al, 1997), ATF2 (Fuchs et al, 2000), and p53 (Buschmann et al, 2001). Our studies thus add ⌬FosB to this list of transcription factors whose functional activity is regulated through its phosphorylated-dependent stability.…”
Section: Discussionmentioning
confidence: 96%
“…Although the present study does not deal with expression of these proteins after exposure to NMDA, there is emerging evidence for expression of the c‐ fos gene as well as the c‐Fos protein in vitro through activation of NMDA receptor, as described above. The systemic administration of NMDA results in transient expression of c‐Fos and Fra‐2 proteins in murine hippocampus in vivo (Manabe et al, 2001). Identification of family member proteins is undoubtedly crucial for elucidation of molecular mechanisms underlying consolidation of transient extracellular NMDA signals but is beyond the scope of the present study, which focuses on the search for the origin of intracellular free Ca 2+ ions required for the potentiation after brief exposure to NMDA.…”
Section: Discussionmentioning
confidence: 99%
“…Hippocampal preparations cultured for 3, 5, and 9 DIV were collected in homogenizing buffer [20 mM Tris‐HCl buffer (pH 7.5) containing 1 mM EDTA, 1 mM EGTA, 10 mM NaF, 10 mM sodium β‐glycerophosphate (NaGP), 10 mM sodium pyrophosphate, 1 mM sodium orthovanadate, and 1 μg/ml of various protease inhibitors [( p ‐amidinophenyl)methanesulfonyl fluoride, leupeptin, antipain, and benzamidine], as described elsewhere (Manabe et al, 2001). Buffer and other solutions used in this study were all sterilized before each use by filtration though a nitrocellulose membrane filter with a pore size of 0.22 μm to avoid possible microbial contamination (Yoneda and Ogita, 1989).…”
Section: Methodsmentioning
confidence: 99%
“…Immunoblotting was performed as previously described 42,43 with minor modifications. Anti-HMGA1 (HMG-I(Y) (N-19)) and anti-U1-70K (U1 SnRNP 70 (C-18)) goat polyclonal antibodies were purchased (Santa Cruz Biotechnology).…”
Section: Immunoblotting Assaysmentioning
confidence: 99%